UBS AM’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$78.3M Buy
4,671,735
+1,134,411
+32% +$19M 0.02% 586
2025
Q1
$54.4M Buy
3,537,324
+196,261
+6% +$3.02M 0.01% 671
2024
Q4
$73.6M Sell
3,341,063
-36,454
-1% -$803K 0.02% 580
2024
Q3
$60.9M Buy
3,377,517
+2,376,668
+237% +$42.8M 0.02% 633
2024
Q2
$16.3M Sell
1,000,849
-1,222,615
-55% -$19.9M ﹤0.01% 941
2024
Q1
$31.4M Sell
2,223,464
-39,486
-2% -$557K 0.01% 688
2023
Q4
$23.6M Sell
2,262,950
-27,401
-1% -$286K 0.01% 735
2023
Q3
$23.4M Buy
2,290,351
+371,868
+19% +$3.79M 0.01% 734
2023
Q2
$17M Hold
1,918,483
0.01% 807
2023
Q1
$17M Buy
1,918,483
+88,077
+5% +$779K 0.01% 807
2022
Q4
$16.7M Buy
1,830,406
+153,181
+9% +$1.4M 0.01% 798
2022
Q3
$13.5M Sell
1,677,225
-128,515
-7% -$1.04M 0.01% 866
2022
Q2
$13.6M Buy
1,805,740
+5,980
+0.3% +$45K 0.01% 849
2022
Q1
$16.9M Sell
1,799,760
-90,715
-5% -$852K 0.01% 887
2021
Q4
$15.1M Sell
1,890,475
-23,365
-1% -$187K 0.01% 980
2021
Q3
$18.6M Buy
1,913,840
+130,872
+7% +$1.27M 0.01% 888
2021
Q2
$17.7M Sell
1,782,968
-88,857
-5% -$880K 0.01% 920
2021
Q1
$21.6M Sell
1,871,825
-60,855
-3% -$702K 0.01% 845
2020
Q4
$18.7M Sell
1,932,680
-17,610
-0.9% -$170K 0.01% 864
2020
Q3
$17.6M Buy
1,950,290
+14,913
+0.8% +$134K 0.01% 810
2020
Q2
$23.9M Sell
1,935,377
-57,980
-3% -$715K 0.01% 693
2020
Q1
$17.9M Buy
1,993,357
+91,645
+5% +$823K 0.01% 701
2019
Q4
$18.6M Buy
1,901,712
+177,129
+10% +$1.74M 0.01% 794
2019
Q3
$11.9M Buy
1,724,583
+190,023
+12% +$1.31M 0.01% 903
2019
Q2
$14.2M Sell
1,534,560
-302,680
-16% -$2.79M 0.01% 851
2019
Q1
$28.8M Sell
1,837,240
-568,823
-24% -$8.92M 0.02% 658
2018
Q4
$37.1M Buy
2,406,063
+984,975
+69% +$15.2M 0.03% 544
2018
Q3
$30.6M Sell
1,421,088
-13,123
-0.9% -$283K 0.02% 640
2018
Q2
$34.9M Buy
1,434,211
+51,428
+4% +$1.25M 0.03% 623
2018
Q1
$23.6M Sell
1,382,783
-661
-0% -$11.3K 0.02% 728
2017
Q4
$26.2M Buy
1,383,444
+13,930
+1% +$264K 0.02% 672
2017
Q3
$24.1M Buy
1,369,514
+10,565
+0.8% +$186K 0.02% 695
2017
Q2
$45.1M Sell
1,358,949
-6,213
-0.5% -$206K 0.04% 447
2017
Q1
$43.8M Sell
1,365,162
-639,598
-32% -$20.5M 0.04% 446
2016
Q4
$72.7M Buy
2,004,760
+1,205,253
+151% +$43.7M 0.08% 266
2016
Q3
$36.8M Sell
799,507
-1,898,185
-70% -$87.3M 0.04% 470
2016
Q2
$136M Sell
2,697,692
-317,981
-11% -$16M 0.15% 156
2016
Q1
$161M Buy
3,015,673
+624,629
+26% +$33.4M 0.19% 120
2015
Q4
$157M Buy
2,391,044
+583,167
+32% +$38.3M 0.18% 134
2015
Q3
$102M Buy
1,807,877
+473,814
+36% +$26.8M 0.11% 206
2015
Q2
$78.8M Sell
1,334,063
-216,121
-14% -$12.8M 0.08% 284
2015
Q1
$96.6M Buy
1,550,184
+940,062
+154% +$58.6M 0.09% 245
2014
Q4
$35.1M Sell
610,122
-13,864
-2% -$797K 0.03% 534
2014
Q3
$33.5M Sell
623,986
-192,554
-24% -$10.3M 0.03% 540
2014
Q2
$42.8M Sell
816,540
-37,079
-4% -$1.94M 0.04% 456
2014
Q1
$45.1M Sell
853,619
-251,636
-23% -$13.3M 0.05% 406
2013
Q4
$44.3M Sell
1,105,255
-979,907
-47% -$39.3M 0.05% 380
2013
Q3
$78.8M Buy
2,085,162
+213,283
+11% +$8.06M 0.1% 234
2013
Q2
$73.4M Buy
+1,871,879
New +$73.4M 0.09% 241